These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3976784)

  • 1. Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone.
    Ottosson UB; Johansson BG; von Schoultz B
    Am J Obstet Gynecol; 1985 Mar; 151(6):746-50. PubMed ID: 3976784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral progesterone and estrogen/progestogen therapy. Effects of natural and synthetic hormones on subfractions of HDL cholesterol and liver proteins.
    Ottosson UB
    Acta Obstet Gynecol Scand Suppl; 1984; 127():1-37. PubMed ID: 6596830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
    Miller VT; Muesing RA; LaRosa JC; Stoy DB; Phillips EA; Stillman RJ
    Obstet Gynecol; 1991 Feb; 77(2):235-40. PubMed ID: 1846437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E; Mälkönen M; Manninen V
    N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women.
    Paganini-Hill A; Dworsky R; Krauss RM
    Am J Obstet Gynecol; 1996 Mar; 174(3):897-902. PubMed ID: 8633665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone.
    Chen FP; Lee N; Soong YK
    J Reprod Med; 1998 Jul; 43(7):568-74. PubMed ID: 9693406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoprotein changes in climacteric women induced by sequential therapy with natural estrogens and medroxy-progesterone acetate or norgestrel.
    Vejtorp M; Christensen MS; Vejtorp L; Larsen JF
    Acta Obstet Gynecol Scand; 1986; 65(5):391-5. PubMed ID: 3535357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an antiestrogen on subfractions of HDL cholesterol during estrogen replacement therapy.
    Ottosson UB; Carlström K; Johansson BG; von Schoultz B
    Gynecol Obstet Invest; 1984; 18(3):140-6. PubMed ID: 6436151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen induction of liver proteins and high-density lipoprotein cholesterol: comparison between estradiol valerate and ethinyl estradiol.
    Ottosson UB; Carlström K; Johansson BG; von Schoultz B
    Gynecol Obstet Invest; 1986; 22(4):198-205. PubMed ID: 3817605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone replacement therapy and plasma lipoproteins.
    Taskinen MR
    J Intern Med; 1995 Nov; 238(5):385-7. PubMed ID: 7595177
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
    Barnes RB; Roy S; Lobo RA
    Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hormone replacement therapy on blood serum lipids in postmenopausal women with type 2 diabetes].
    Kozlov SG; Dotsenko IuV; Sankova AV; Liakishev AA; Tvorogova MG; Afanas'eva OI; Titov VN; Pokrovskiĭ SN; Naumov VG
    Kardiologiia; 2002; 42(7):47-52. PubMed ID: 12494113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipids and lipoproteins in continuous or cyclic medroxyprogesterone acetate treatment in postmenopausal women treated with conjugated estrogens.
    Yancey MK; Hannan CJ; Plymate SR; Stone IK; Friedl KE; Wright JR
    Fertil Steril; 1990 Nov; 54(5):778-82. PubMed ID: 2226911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
    Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of norgestrel- versus cyproterone acetate-containing hormone replacement therapy on lipid-lipoprotein metabolism.
    Panyakhamlerd K; Limpaphayom K; Taechakraichana N; Chaikittisilpa S; Pasatrat S; Pojanasopanakun S
    J Med Assoc Thai; 2000 Jul; 83(7):764-70. PubMed ID: 10932511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
    Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
    Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.